miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3)
about
A feedback regulatory loop between HIF-1α and miR-21 in response to hypoxia in cardiomyocytesMicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapyThe Regulatory Role of MicroRNAs in EMT and CancerInhibition of microRNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta.DNA methylation-mediated repression of miR-941 enhances lysine (K)-specific demethylase 6B expression in hepatoma cells.Let-7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora-B.microRNA 490-3P enhances the drug-resistance of human ovarian cancer cellsMicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cellsMicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.miR-346 and miR-138 competitively regulate hTERT in GRSF1- and AGO2-dependent manners, respectively.Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell MalignancymiR-490-5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA.The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.MicroRNA-490 inhibits tumorigenesis and progression in breast cancer.Poly r(C) binding protein (PCBP) 1 is a negative regulator of thyroid carcinoma.Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis.Regulation of the unfolded protein response by microRNAs.An integrative CGH, MSI and candidate genes methylation analysis of colorectal tumors.Endoplasmic reticulum-Golgi intermediate compartment protein 3 knockdown suppresses lung cancer through endoplasmic reticulum stress-induced autophagy.Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2.Epigenetics of hepatocellular carcinoma: role of microRNAThe role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.miRNA in hepatocellular carcinoma.Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma.Identification of microRNA signature and potential pathway targets in prostate cancer.Poly r(C) binding protein (PCBP) 1 expression is regulated at the post-translation level in thyroid carcinoma.MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells.The long noncoding RNA colon cancer-associated transcript-1/miR-490 axis regulates gastric cancer cell migration by targeting hnRNPA1.MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancer.MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.
P2860
Q24300231-3747EDFD-4BCB-44AB-BE80-6E839670ACEAQ26853284-A76FF673-8A05-4247-B24E-5CFC18838ED4Q27005850-9155EEE6-185E-45C1-AE8F-2514153AC520Q28391426-EDB9817A-5A37-4F19-9C58-FE072FAD3FCFQ31812546-FD076164-45E9-4B36-B8B5-3B99460D717FQ34107419-A6EFF74D-CDBE-4C90-8FFD-D889B2482A0EQ34121288-641B64D4-600D-429E-A43C-BC4B659989FDQ34150950-879C76C6-C186-4BDB-806B-2CE88759288CQ35715931-E0CAB17B-02D2-4A11-B0F0-ED2C62B6AF4AQ35740131-53C3A15E-2937-47FF-8558-696AEF212A88Q35742454-1F02C744-0D8A-4022-9BBA-5A362151A049Q35881020-A93E5426-28F2-4D3F-8642-C0FAE22F962CQ36216239-3A9C1CEB-DB03-47D0-8250-B97FA38308C0Q36340244-E4118908-3064-413E-A667-67A930354F05Q36381912-86AFBA95-D9B8-4113-917C-78CAA36D2FF1Q36555180-EC36EAEA-3F63-4A09-9315-300C141D3956Q36962563-D93CA341-D5B1-4A72-B0F3-0D3B4C3F94D0Q37138386-9CCF5B0D-61A8-407B-82EC-4AC23B204EEBQ37228032-FB89967E-5972-40E0-B447-349F28DC42ABQ37332728-BC4EB822-2278-48A2-84AB-06B51721E803Q37423378-ACE61310-B50C-4816-A5E5-6618BC89C8F7Q37520573-C88E5F95-5F01-4AF6-A89A-17B7C53C9F04Q37662233-61CC034A-8283-4A78-B462-FC1534CD511FQ37681322-64F51B93-1D00-4D4C-B942-25DA8A94B220Q37684204-D3622065-A733-41E6-BB3F-D739DCD13832Q37732994-D90009B7-40F9-4A09-A608-074D1D713DB6Q38136179-46DCCF53-2DA4-4586-9BBB-E66BC51A40A7Q38164571-58DE327E-762F-433B-9978-AEEA7EE0CAAFQ38231531-D5210476-ABC0-4F77-80DB-D17650AE52D5Q38334014-F39E21A0-FB7D-4915-A4A6-0C0882FB6F14Q38728193-8E5AA64D-C6A0-471D-9EC3-658866E4744FQ38740584-FF188D19-BB9C-4A9E-A671-94B88814EA05Q38743265-7D42B48E-1B5C-4C14-B6A9-214F4832A8A1Q38751253-AEB2C939-E253-4502-B75A-D68A498E018AQ38798201-749EFF83-010A-4EB9-A39D-6A9D6AB76880Q38807193-C3842752-E132-4DDA-A6BD-B7D5C0C10CB8Q38830564-28F41114-1B33-4FD0-BC87-CAD06DD7F479Q38837784-49E6AF1C-C184-46D5-938C-AFCF684B5C01Q38852743-4CA50BE6-FF57-4C7A-9B73-9BCD4EE6B1A0Q38913514-FBF0D686-3C09-4891-B872-FA88B390BED6
P2860
miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
miR-490-3p modulates cell grow ...... compartment protein 3 (ERGIC3)
@ast
miR-490-3p modulates cell grow ...... compartment protein 3 (ERGIC3)
@en
type
label
miR-490-3p modulates cell grow ...... compartment protein 3 (ERGIC3)
@ast
miR-490-3p modulates cell grow ...... compartment protein 3 (ERGIC3)
@en
prefLabel
miR-490-3p modulates cell grow ...... compartment protein 3 (ERGIC3)
@ast
miR-490-3p modulates cell grow ...... compartment protein 3 (ERGIC3)
@en
P2093
P2860
P356
P1476
miR-490-3p modulates cell grow ...... compartment protein 3 (ERGIC3)
@en
P2093
P2860
P304
P356
10.1074/JBC.M112.410506
P407
P577
2012-12-04T00:00:00Z